This company has been marked as potentially delisted and may not be actively trading. Neuralstem (CUR) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsTrendsBuy This Stock CUR vs. FRTX, APTO, ONVO, GENE, SQZ, SRNE, KRBP, TCBP, GNCAQ, and GNCAShould you be buying Neuralstem stock or one of its competitors? The main competitors of Neuralstem include Fresh Tracks Therapeutics (FRTX), Aptose Biosciences (APTO), Organovo (ONVO), Genetic Technologies (GENE), SQZ Biotechnologies (SQZ), Sorrento Therapeutics (SRNE), Kiromic BioPharma (KRBP), TC Biopharm (TCBP), Genocea Biosciences (GNCAQ), and Genocea Biosciences (GNCA). These companies are all part of the "medical" sector. Neuralstem vs. Its Competitors Fresh Tracks Therapeutics Aptose Biosciences Organovo Genetic Technologies SQZ Biotechnologies Sorrento Therapeutics Kiromic BioPharma TC Biopharm Genocea Biosciences Genocea Biosciences Neuralstem (NASDAQ:CUR) and Fresh Tracks Therapeutics (NASDAQ:FRTX) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their earnings, profitability, media sentiment, valuation, institutional ownership, analyst recommendations, risk and dividends. Which has preferable valuation and earnings, CUR or FRTX? Neuralstem has higher earnings, but lower revenue than Fresh Tracks Therapeutics. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNeuralstem$260K5.86-$4.93MN/AN/AFresh Tracks Therapeutics$10.06M0.56-$5.69M-$1.41-0.66 Which has more risk and volatility, CUR or FRTX? Neuralstem has a beta of 1.81, suggesting that its stock price is 81% more volatile than the S&P 500. Comparatively, Fresh Tracks Therapeutics has a beta of 0.54, suggesting that its stock price is 46% less volatile than the S&P 500. Do institutionals & insiders hold more shares of CUR or FRTX? 38.3% of Neuralstem shares are held by institutional investors. Comparatively, 25.0% of Fresh Tracks Therapeutics shares are held by institutional investors. 5.4% of Neuralstem shares are held by insiders. Comparatively, 0.2% of Fresh Tracks Therapeutics shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term. Is CUR or FRTX more profitable? Fresh Tracks Therapeutics has a net margin of 0.00% compared to Neuralstem's net margin of -39,417.64%. Fresh Tracks Therapeutics' return on equity of 0.00% beat Neuralstem's return on equity.Company Net Margins Return on Equity Return on Assets Neuralstem-39,417.64% -170.51% -110.16% Fresh Tracks Therapeutics N/A N/A N/A Does the media refer more to CUR or FRTX? In the previous week, Neuralstem's average media sentiment score of 0.00 equaled Fresh Tracks Therapeutics'average media sentiment score. Company Overall Sentiment Neuralstem Neutral Fresh Tracks Therapeutics Neutral SummaryNeuralstem beats Fresh Tracks Therapeutics on 5 of the 9 factors compared between the two stocks. Get Neuralstem News Delivered to You Automatically Sign up to receive the latest news and ratings for CUR and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CUR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CUR vs. The Competition Export to ExcelMetricNeuralstemBiological Products, Except Diagnostic IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.52M$205.22M$5.56B$9.03BDividend YieldN/AN/A5.22%3.99%P/E RatioN/AN/A27.6920.25Price / Sales5.86223.65389.63163.09Price / CashN/A22.4436.8958.10Price / Book0.115.618.035.67Net Income-$4.93M-$96.61M$3.18B$249.21M Neuralstem Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CURNeuralstemN/A$0.73-0.6%N/A-83.9%$1.52M$260K0.006FRTXFresh Tracks TherapeuticsN/A$0.94-0.5%N/A-0.5%$5.59M$10.06M-0.6620APTOAptose Biosciences1.7939 of 5 starsN/A$6.00+∞N/A$3.66MN/A-0.5831Gap DownHigh Trading VolumeONVOOrganovoN/AN/AN/AN/A$3.47M$122K-2.4020Gap UpGENEGenetic TechnologiesN/A$0.77flatN/AN/A$3.37M$7.66M0.0050High Trading VolumeSQZSQZ BiotechnologiesN/A$0.03flatN/AN/A$826K$18.16M-0.011,620SRNESorrento Therapeutics0.6945 of 5 stars$0.00-36.4%N/A-88.2%$772K$60.32M0.00800News CoverageGap DownKRBPKiromic BioPharmaN/AN/AN/AN/A$330KN/A-0.0660Gap DownHigh Trading VolumeTCBPTC BiopharmN/A$0.68-55.8%$48.00+6,948.5%-99.5%$279K$4.76M0.0080High Trading VolumeGNCAQGenocea BiosciencesN/AN/AN/AN/A$6KN/A0.0070GNCAGenocea BiosciencesN/AN/AN/AN/A$6K$1.91M0.0070 Related Companies and Tools Related Companies FRTX Alternatives APTO Alternatives ONVO Alternatives GENE Alternatives SQZ Alternatives SRNE Alternatives KRBP Alternatives TCBP Alternatives GNCAQ Alternatives GNCA Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CUR) was last updated on 7/6/2025 by MarketBeat.com Staff From Our PartnersThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredTrump’s BIGGEST setup yet.After another undefeated quarter, “Market Wizard” Larry Benedict is sounding the alarm on a $194 trillion mark...Brownstone Research | SponsoredWhy Elon is funding the “Quantum Power Grid”Elon knows the future isn’t about smarter AI — it’s about powering it. And this new technology is quietly b...True Market Insiders | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Neuralstem, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Neuralstem With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CUR Stock Alerts